Thierer Mark 4/A

What Happened
Mark Thierer, a director of P3 Health Partners Inc. (PIII), was granted 4,000 restricted stock units (RSUs) on August 6, 2025. The RSUs were awarded at $0.00 per unit (a typical equity grant rather than a purchase) and each RSU represents a right to receive one share of Class A common stock upon vesting. The RSUs vest upon the earlier of the company's 2026 annual stockholder meeting or the one-year anniversary of the grant date. This Form 4 is an amended filing.

Key Details

• Transaction type/code: Award/Grant (A).
• Grant date: August 6, 2025. Price: $0.00 per RSU. Total units: 4,000 RSUs.
• Vesting: Earlier of the 2026 annual meeting or one-year anniversary of the grant (per footnote F1).
• Filing: Amended Form 4 filed January 23, 2026 to correct prior ownership reporting (footnote F2). The amendment adjusts beneficial ownership to reflect the 1-for-50 reverse stock split effective April 11, 2025 and to include certain indirectly owned securities.
• Indirect holdings: The reporting person and Nasrin Thierer have voting and dispositive power over securities held by AssetBlue Ventures, LLC (footnote F3).
• Shares owned after transaction: Not specified in the provided data; the amended filing corrects prior figures to reflect the reverse split and indirect ownership.
• Timeliness: Amended filing was submitted several months after the grant date (noted as amended/late), which corrects prior reporting errors.

Context
RSU grants are common compensation for directors and convert to shares only upon vesting; they are not an immediate cash purchase or sale and do not, by themselves, signal buying or selling intent. The amendment primarily fixes reporting (reverse split and indirect ownership) rather than changing the substance of the grant. Retail investors should note the vesting timeline to understand when these units could dilute outstanding shares or be sold in the market.